These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24570360)

  • 1. [Neurological disorders and the blood-brain barrier. Strategies and limitations for drug delivery to the brain].
    Domínguez A; Álvarez A; Suárez-Merino B; Goñi-de-Cerio F
    Rev Neurol; 2014 Mar; 58(5):213-24. PubMed ID: 24570360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier: clinical implications for drug delivery to the brain.
    De Boer AG; Breimer DD
    J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
    Dilnawaz F; Sahoo SK
    Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.
    Govender T; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Modi G; Naidoo D; Pillay V
    Pharm Dev Technol; 2017 Jun; 22(4):476-486. PubMed ID: 27268737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
    Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
    Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pericytes and the blood-brain barrier: recent advances and implications for the delivery of CNS therapy.
    Armulik A; Mäe M; Betsholtz C
    Ther Deliv; 2011 Apr; 2(4):419-22. PubMed ID: 22826851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
    Mc Carthy DJ; Malhotra M; O'Mahony AM; Cryan JF; O'Driscoll CM
    Pharm Res; 2015 Apr; 32(4):1161-85. PubMed ID: 25446769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier: an impediment to neuropharmaceuticals.
    Henderson JT; Piquette-Miller M
    Clin Pharmacol Ther; 2015 Apr; 97(4):308-13. PubMed ID: 25670372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for delivering therapeutics across the blood-brain barrier.
    Terstappen GC; Meyer AH; Bell RD; Zhang W
    Nat Rev Drug Discov; 2021 May; 20(5):362-383. PubMed ID: 33649582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting specific cells in the brain with nanomedicines for CNS therapies.
    Zhang F; Lin YA; Kannan S; Kannan RM
    J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology of the neurovascular unit: implications for drug delivery across the blood-brain barrier.
    McCarty JH
    Assay Drug Dev Technol; 2005 Feb; 3(1):89-95. PubMed ID: 15798399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.
    Smith MW; Gumbleton M
    J Drug Target; 2006 May; 14(4):191-214. PubMed ID: 16777679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.